Elsevier Is the New Publisher of Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Oxford, UK, 5th January 2011 – Elsevier, the world's leading publisher of scientific, technical and medical information, announced today that it has become the new publisher of the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) journal Value in Health.
Value in Health is a multidisciplinary peer-reviewed journal reporting on outcomes research evaluations of medical technologies including pharmaceuticals, biologics, devices, medical procedures, and other health care interventions. The journal is published eight times a year.
The Journal provides a scientific forum for communicating clinical, economic, and patient-reported outcomes research methods and findings, furthering ISPOR's mission that 'society allocates scarce health care resources wisely, fairly, and efficiently. Value in Healthis also a sounding board for the discussion of health policy issues related to health economics and outcomes research studies associated with all medical technologies. Topics include budget impact/cost-effectiveness/cost-utility/cost-benefit analysis, health utilities/preferences, patient-reported outcomes/health-related quality of life/health status research, health technology assessment, disease management, with study designs (prospective, retrospective, observational and clinical trials, and modeling), and critical reviews of existing literature.
# # #
ISPOR is a (not-for-profit) member driven, international, educational and scientific organization promoting the science of pharmacoeconomics and outcomes research (clinical, economic, and patient-reported outcomes) and the translation of outcomes research into health care decisions. ISPOR has over 5,500 active members from 86 countries and 3,300 members in its 42 regional chapters totaling over 8,900 members.
ISPOR represents researchers and practitioners including pharmacists, physicians, economists, public health and other professionals involved in pharmacoeconomic analysis and health outcomes assessment as well as users of this information in health care decisions in government, hospitals, managed care, and pharmacy benefit design organizations.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+44 020 7424 4404